Bioburden Testing Market 2021-26: Size, Share, Analysis and Growth Report

(MENAFN- IMARC Group) According to the latest report by IMARC Group, titled “Bioburden Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global bioburden testing market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the global bioburden testing market to grow at a CAGR of around 12% during 2021-2026. Bioburden testing helps in measuring the total viable count of microbial contamination in a product. It is extensively used in the pharmaceutical industry to analyze and understand the different types and amounts of microorganisms in sterile medical devices throughout the production process. Before the test, a suitability experiment is usually carried out to ensure the effectiveness of the testing method while recovering the microorganisms present on the device.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Market Trends:

At present, the government authorities of several countries are implementing stringent policies and regulations to validate the sterilization process of medical devices. This represents one of the primary factors escalating the demand for bioburden testing. Furthermore, the growing utilization of single-use medical items is also providing a thrust to the global market. Moreover, as bioburden testing is an essential part of the microbiological monitoring program while manufacturing sterile products, it is gaining traction in the cosmetics sector for maintaining the overall safety and performance of the packaged goods. Besides this, a rapid increase in coronavirus cases is augmenting the need for bioburden reduction systems that utilize dry heat to support the reuse of particulate filtering facepiece respirators (FFRs). All of these above-mentioned factors will continue to drive the global market for bioburden testing in the coming years.

Key Market Segmentation:                

Competitive Landscape:                        

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:


Becton Dickinson and Company
Biomérieux SA (Compagnie Merieux Alliance)
Charles River Laboratories Inc
Merck KGaA
Nelson Laboratories LLC (Sotera Health LLC)
North American Science Associates Inc.
Pacific BioLabs Inc.
SGS SA
Thermo Fisher Scientific Inc
Wuxi Apptec


Breakup by Product:                          


Consumables

Culture Media
Reagents
Others


Instruments

Automated Microbial Identification Systems
Polymerase Chain Reaction Systems
Microscopes
Others




Breakup by Test Type:


Aerobic Count Testing
Anaerobic Count Testing
Fungi/Mold Count Testing
Spores Count Testing
Others


Breakup by Application:


Raw Material Testing
Medical Devices Testing
In-process Testing
Sterilization Validation Testing
Others


Breakup by End User:


Pharmaceutical and Biotechnology Companies
Medical Device Companies
Contract Manufacturing Organizations (CMOs)
Food and Beverages Companies
Others


Breakup by Region:


North America (United States, Canada)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)


Key highlights of the Report:


Market Performance (2015-2020)
Market Outlook (2021-2026)
COVID-19 Impact on the Market
Porter’s Five Forces Analysis
Historical, Current and Future Market Trends
Market Drivers and Success Factors
SWOT Analysis
Structure of the Market
Value Chain Analysis
Comprehensive Mapping of the Competitive Landscape


Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.